Let's talk Controversies in Modern Eye Care: what to expect

Video

Hear from Robert Maloney, MD, about what to expect—and what he's excited about—for this year's 2023 Controversies in Modern Eye Care meeting held this April in Los Angeles, California.

Robert Maloney, MD, of the Maloney-Shamie Vision Institute and one of the co-chairs of the 17th annual Controversies in Modern Eye Care meeting, caught up with Optometry Times®' editor Kassi Jackson to share what attendees can expect from the April meeting in Los Angeles.

Editor's note: This transcript has been edited for clarity.

Jackson:

Hi everyone, I'm Kassi Jackson with Optometry Times, and I'm sitting down with Dr. Robert Maloney, who's presenting at the 17th annual Controversies in Modern Eye Care meeting in Los Angeles, California, this year in April 2023. Welcome Dr. Maloney, thank you for taking the time to talk with us.

Maloney:

Yes, it's great to hear you .

Jackson:

Why should practitioners be excited about this year's controversies and modern eye care meeting?

Maloney:

So Controversies meeting is, we think, a wonderful meeting because it focuses on areas of controversy rather than kind of the didactic stuff that's so often part of presentations. What are the difficult questions? What are the hard management issues? We try and stick to those questions, as opposed to giving our attendees lectures they may hear in school. And so I think that really sets us apart. It's also a fun meeting. It's very social, we have enough breaks that people can catch up with their friends—a lot of times see old colleagues from optometry school who they haven't seen for a while. And so it makes it a fun meeting and one that's educational.

Jackson:

That's awesome. And what are you most excited to share at this meeting?

Maloney:

Well, what I'm most excited about is seeing old friends. And this is the one meeting a year where I get to see a number of my physician colleagues in the community to catch up to find out how their practices are going, how their families are going [and] to share a cup of coffee. And for me, that's the part I enjoy the most.

Jackson:

That's wonderful. So what can clinicians expect from this year's meeting?

Maloney:

Clinicians can expect to have a high-level educational experience that's oriented to people who are smart, thoughtful, knowledgeable about their field, but want to take the practice to the next level.

Jackson:

And what sets the Controversies meeting apart from other conferences?

Maloney:

The Controversies meeting, I think is really set apart by its focus on areas of controversy, rather than simply reviewing the material one learns in school or in residency. And I think that makes it more interesting meeting and very useful for day-to-day practice.

Jackson:

And is there anything else you'd like to mention that we haven't touched on?

Maloney:

Dammit, you hit it all.

Jackson:

Wonderful. Well, Dr. Maloney, thank you so much for your time today.

Visit here to register for the conference.

Recent Videos
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Dr. Stephanie Woo discusses the upcoming CRU Eye Symposium
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Dr. Ben Casella highlights the importance of SECO to the optometric community.
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Dr Ben Gaddie chats about his dry eye presentation at SECO and ocular surface disease.jpg
Dr. Julie Rodman previews her SECO presentations
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
© 2025 MJH Life Sciences

All rights reserved.